ACTR-44. PRELIMINARY RESULTS FROM THE NCT02770378 PROOF-OF-CONCEPT CLINICAL TRIAL ASSESSING THE SAFETY OF THE CUSP9v3 PROTOCOL COMBINED WITH METRONOMIC TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA

BACKGROUND: Despite refinements of neurosurgical techniques and emerging adjuvant therapies, patients with recurrent glioblastoma continue to face a dismal prognosis. We report preliminary results of a clinical trial evaluating a protocol of 9 repurposed drugs (aprepitant, minocyclin, disulfiram, ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Halatsch, Marc-Eric, Kast, Richard, Karpel-Massler, Georg, Schmidt, Carl, Schmelzle, Birgit, Awad, Fadi, Panther, Patricia, Heiland, Tim
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216384/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados